Matches in SemOpenAlex for { <https://semopenalex.org/work/W1483287894> ?p ?o ?g. }
- W1483287894 endingPage "243" @default.
- W1483287894 startingPage "236" @default.
- W1483287894 abstract "Compared with the proven utility of flow cytometry immunophenotyping (FCI) analysis in the workup of myelodysplastic syndromes (MDS), immunophenotypic alterations in myeloproliferative neoplasms (MPN) have been less studied and the potential utility of FCI is not defined.Bone marrow (BM) samples of 83 Philadelphia-negative MPN patients were assessed by multicolor FCI including 27 with essential thrombocythemia (ET); 17 polycythemia vera (PV); 33 primary myelofibrosis (PMF) and 6 MPN-unclassifiable (MPN-U). The time interval from initial diagnosis of MPN to FCI analysis was 18 months (0-370). Ninety-five age-matched MDS patients with a similar BM blast count were included for comparison.Immunophenotypic alterations, either in CD34(+) cells or myelomonocytic cells, were detected in 82 of 83 (99%) MPN cases. FCI abnormalities were more frequently observed in cases with substantial myelofibrosis but not different between PMF and fibrotic stage of ET/PV. Furthermore, FCI abnormalities were more frequent in cases with ≥5% BM blasts and/or circulating blasts (P = 0.006); as well as cases with an abnormal karyotype (P = 0.036); but not associated with morphologic dysplasia or JAK2 mutation status. Comparing with MDS, FCI abnormalities were overall less pronounced in MPN cases (P = 0.001).MPNs exhibit frequent immunophenotypic alterations, more pronounced in cases with adverse histopathologic features. These findings illustrate that immunophenotypic alterations are a part of constellational findings in MPN, and correlate progressively with disease stage. The study results also suggest a role of FCI in diagnosis of MPN and monitoring disease over time and after therapy." @default.
- W1483287894 created "2016-06-24" @default.
- W1483287894 creator A5000027373 @default.
- W1483287894 creator A5028591457 @default.
- W1483287894 creator A5057959540 @default.
- W1483287894 creator A5058164746 @default.
- W1483287894 creator A5065815115 @default.
- W1483287894 creator A5081199838 @default.
- W1483287894 creator A5089295627 @default.
- W1483287894 date "2014-12-30" @default.
- W1483287894 modified "2023-10-18" @default.
- W1483287894 title "Flow cytometry immunophenotypic analysis of philadelphia-negative myeloproliferative neoplasms: Correlation with histopathologic features" @default.
- W1483287894 cites W1900310489 @default.
- W1483287894 cites W1964893697 @default.
- W1483287894 cites W2004511852 @default.
- W1483287894 cites W2010587952 @default.
- W1483287894 cites W2011253478 @default.
- W1483287894 cites W2013169247 @default.
- W1483287894 cites W2014785376 @default.
- W1483287894 cites W2032657992 @default.
- W1483287894 cites W2059209319 @default.
- W1483287894 cites W2059750529 @default.
- W1483287894 cites W2070261954 @default.
- W1483287894 cites W2080104001 @default.
- W1483287894 cites W2098258699 @default.
- W1483287894 cites W2101282898 @default.
- W1483287894 cites W2107139993 @default.
- W1483287894 cites W2112730132 @default.
- W1483287894 cites W2113792044 @default.
- W1483287894 cites W2115211756 @default.
- W1483287894 cites W2140289802 @default.
- W1483287894 cites W2140401441 @default.
- W1483287894 cites W2141826954 @default.
- W1483287894 cites W2162805244 @default.
- W1483287894 cites W2263869051 @default.
- W1483287894 doi "https://doi.org/10.1002/cyto.b.21215" @default.
- W1483287894 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25557358" @default.
- W1483287894 hasPublicationYear "2014" @default.
- W1483287894 type Work @default.
- W1483287894 sameAs 1483287894 @default.
- W1483287894 citedByCount "4" @default.
- W1483287894 countsByYear W14832878942016 @default.
- W1483287894 countsByYear W14832878942018 @default.
- W1483287894 countsByYear W14832878942021 @default.
- W1483287894 countsByYear W14832878942023 @default.
- W1483287894 crossrefType "journal-article" @default.
- W1483287894 hasAuthorship W1483287894A5000027373 @default.
- W1483287894 hasAuthorship W1483287894A5028591457 @default.
- W1483287894 hasAuthorship W1483287894A5057959540 @default.
- W1483287894 hasAuthorship W1483287894A5058164746 @default.
- W1483287894 hasAuthorship W1483287894A5065815115 @default.
- W1483287894 hasAuthorship W1483287894A5081199838 @default.
- W1483287894 hasAuthorship W1483287894A5089295627 @default.
- W1483287894 hasConcept C10205521 @default.
- W1483287894 hasConcept C126322002 @default.
- W1483287894 hasConcept C142724271 @default.
- W1483287894 hasConcept C196166836 @default.
- W1483287894 hasConcept C203014093 @default.
- W1483287894 hasConcept C2775894508 @default.
- W1483287894 hasConcept C2778837598 @default.
- W1483287894 hasConcept C2780007613 @default.
- W1483287894 hasConcept C2780076729 @default.
- W1483287894 hasConcept C2780817109 @default.
- W1483287894 hasConcept C2781057849 @default.
- W1483287894 hasConcept C2781107747 @default.
- W1483287894 hasConcept C28328180 @default.
- W1483287894 hasConcept C54355233 @default.
- W1483287894 hasConcept C553184892 @default.
- W1483287894 hasConcept C71924100 @default.
- W1483287894 hasConcept C86803240 @default.
- W1483287894 hasConcept C90924648 @default.
- W1483287894 hasConceptScore W1483287894C10205521 @default.
- W1483287894 hasConceptScore W1483287894C126322002 @default.
- W1483287894 hasConceptScore W1483287894C142724271 @default.
- W1483287894 hasConceptScore W1483287894C196166836 @default.
- W1483287894 hasConceptScore W1483287894C203014093 @default.
- W1483287894 hasConceptScore W1483287894C2775894508 @default.
- W1483287894 hasConceptScore W1483287894C2778837598 @default.
- W1483287894 hasConceptScore W1483287894C2780007613 @default.
- W1483287894 hasConceptScore W1483287894C2780076729 @default.
- W1483287894 hasConceptScore W1483287894C2780817109 @default.
- W1483287894 hasConceptScore W1483287894C2781057849 @default.
- W1483287894 hasConceptScore W1483287894C2781107747 @default.
- W1483287894 hasConceptScore W1483287894C28328180 @default.
- W1483287894 hasConceptScore W1483287894C54355233 @default.
- W1483287894 hasConceptScore W1483287894C553184892 @default.
- W1483287894 hasConceptScore W1483287894C71924100 @default.
- W1483287894 hasConceptScore W1483287894C86803240 @default.
- W1483287894 hasConceptScore W1483287894C90924648 @default.
- W1483287894 hasIssue "4" @default.
- W1483287894 hasLocation W14832878941 @default.
- W1483287894 hasLocation W14832878942 @default.
- W1483287894 hasOpenAccess W1483287894 @default.
- W1483287894 hasPrimaryLocation W14832878941 @default.
- W1483287894 hasRelatedWork W1483287894 @default.
- W1483287894 hasRelatedWork W1967018160 @default.
- W1483287894 hasRelatedWork W2085444369 @default.
- W1483287894 hasRelatedWork W2182419105 @default.